0001144204-16-103676.txt : 20160630 0001144204-16-103676.hdr.sgml : 20160630 20160519170050 ACCESSION NUMBER: 0001144204-16-103676 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20160519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sensus Healthcare, Inc. CENTRAL INDEX KEY: 0001494891 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 271647271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 851 BROKEN SOUND PARKWAY NW STREET 2: SUITE 215 CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 561-922-5808 MAIL ADDRESS: STREET 1: 851 BROKEN SOUND PARKWAY NW STREET 2: SUITE 215 CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: Sensus Healthcare, LLC DATE OF NAME CHANGE: 20100622 CORRESP 1 filename1.htm

 

 

 

Our File Number: 41163.00001

Writer’s Direct Dial Number: (954) 713-6433

Writer’s Direct Fax Number: (954) 888-2033

Writer’s E-Mail Address: dscileppi@gunster.com

 

 

May 19, 2016

 

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-4561

Attn: Amanda Ravitz, Assistant Director

 

Re:Sensus Healthcare, Inc.
Amendment No. 3 to Registration Statement on Form S-1
Filed May 13, 2016
File No. 333-209451

 

Dear Ms. Ravitz:

 

On behalf of Sensus Healthcare, Inc. (the “Company”) and in response to the comments by the staff (the “Staff”) of the U.S. Securities and Exchange Commission contained in the Staff’s letter dated May 17, 2016 (the “Comment Letter”) to the Company, we are submitting the following information.

 

The responses to the Staff’s comments are numbered to relate to the corresponding comments in the Comment Letter. For your convenience, each of the Company’s responses is preceded with an italicized recitation of the corresponding comment from the Comment Letter.

 

Summary historical financial data, page 10

 

1.We note from your statement of operations for the three months ended March 31, 2016 on page F-4 that your income from operations was $9,588. However, in your summary historical financial data you have presented a loss from operations of $9,588 for the three months ended March 31, 2016. Please revise your filing accordingly

 

RESPONSE: The Company has revised the summary historical financial data on page 10 to address the Staff’s comment.

 

Manufacturing and supply, page 66

 

 

Las Olas Centre, Suite 1400, 450 East Las Olas Boulevard · Fort Lauderdale, FL 33301-4206 | 954-462-2000 | Fax: 954-523-1722 | www.gunster.com 

BOCA RATON · FORT LAUDERDALE · JACKSONVILLE · KEY LARGO · MIAMI · orlando · PALM BEACH · STUART · TALLAHASSEE · tampa · VERO BEACH · WEST PALM BEACh · Winter Park

 

 

U.S. Securities and Exchange Commission

May 19, 2016

Page 2

 

 

2.We note your revisions on pages 14-15 regarding a “preferred” radiation supplier. Please clarify the nature of your arrangement with this “preferred” supplier, such as whether a contract governs the relationship. Also, we note that other suppliers “exist” in the market; however, it’s unclear how readily accessible radiation is from those other suppliers. Please clarify.

 

RESPONSE: The Company has revised the Manufacturing and Supply section of the prospectus beginning on page 66 to address the Staff’s comment.

 

Financial Statements of Sensus Healthcare, Inc.

 

Statement of Stockholders’ Equity, page F-5

 

3.We note that for the three months ended March 31, 2016, you charged offering costs of $4,375 against your additional paid-in capital. Given we did not see disclosures in the filing of any sales of securities during the quarter ended March 31, 2016, please explain to us and revise the filing to disclose the nature of these offering costs and to explain why you recorded the costs against additional paid in capital.

 

RESPONSE: The Company has revised Note 7 to its financial statements to clarify that additional offering costs of $4,375 related to the Company’s December 2015 private offering were incurred during the quarter ended March 31, 2016.

 

We are available to discuss any of the Company’s responses with you at your convenience. Should you have any questions or want to discuss these matters further, please contact me at (954) 713-6433.

 

Very truly yours,

 

 

/s/ David C. Scileppi

David C. Scileppi

 

 

cc:Daniel Morris, U.S. Securities and Exchange Commission

Eric Atallah, U.S. Securities and Exchange Commission

Geoff Kruczek, U.S. Securities and Exchange Commission

Jay Webb, U.S. Securities and Exchange Commission

Joseph C. Sardano, Chief Executive Officer, Sensus Healthcare, Inc.

Arthur Levine, Chief Financial Officer, Sensus Healthcare, Inc.

Ivan K. Blumenthal, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Merav Gershtenman, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

John Gabriel, Marcum LLP

Patrick O’Brien, Marcum LLP

Robert B. Lamm, Gunster

Gustav L. Schmidt, Gunster

 

 

 

 GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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end